Foresite Capital Management III as of June 30, 2021
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 8 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 36.4 | $34M | 2.0M | 17.56 | |
| Natera (NTRA) | 15.3 | $15M | 127k | 113.53 | |
| Acceleron Pharma | 14.5 | $14M | 109k | 125.49 | |
| Epizyme | 8.8 | $8.3M | 998k | 8.31 | |
| Fibrogen (FGEN) | 8.6 | $8.1M | 306k | 26.63 | |
| Verona Pharma Sponsored Ads (VRNA) | 7.7 | $7.3M | 1.1M | 6.54 | |
| Cymabay Therapeutics | 7.6 | $7.2M | 1.6M | 4.36 | |
| Novavax (NVAX) | 1.1 | $1.1M | 5.0k | 212.40 |
